SCHEMBL3864458

SCHEMBL3864458

CC(=S)c1[nH]cnc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94902 0.71
Water SCHEMBL27985161 0.70 GDA (0.96)
Hydrochloric Acid SCHEMBL1776088 0.70 GDA (0.96)
SCHEMBL3885477 0.69 GDA (0.60)
SCHEMBL2202786 0.69 GDA (0.60)
SCHEMBL9708864 0.69 GDA (0.60)
SCHEMBL11801045 0.68 GDA (0.59)
SCHEMBL14357644 0.67 GDA (0.52)
SCHEMBL2491314 0.66 KDM4E (0.64)
SCHEMBL21286900 0.65 GDA (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825254-A4 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LAB INC (US) 2009-01-14 EP disclosed
EP-1825254-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY Prometheus Laboratories, Inc. (US) 2007-08-29 EP disclosed
US-20060216726-A1 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry PROMETHEUS LABORATORIES INC. (US) 2006-09-28 US disclosed
WO-2006055527-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LABORATORIES INC. (US) 2006-05-26 WO disclosed